Maternal pre-eclampsia as a risk factor for developing bronchopulmonary dysplasia in neonates
- PMID: 36239587
- DOI: 10.23736/S2724-5276.22.07019-7
Maternal pre-eclampsia as a risk factor for developing bronchopulmonary dysplasia in neonates
Abstract
Background: The aim of this study was to determine the effect of pre-eclampsia on the development of bronchopulmonary dysplasia (BPD) in preterm infants.
Methods: Retrospective cohort study of infants' ≤32 weeks' gestation admitted to a level-IV single center neonatal intensive care unit from 2014 to 2016. Infants with major congenital anomalies, death or transfer before 28 days were excluded. Infants were stratified by maternal pre-eclampsia status. Demographic, clinical, and laboratory data were reviewed. Logistic regression was used to examine predictors for BPD. Main Outcome measure: The primary outcome was BPD incidence.
Results: Four hundred thirty-two infants met inclusion criteria; 22% developed BPD, of which, 16% had severe BPD. Thirty-eight percent of infants were born to preeclamptic mothers, with 23% of those infants developing BPD. Infants born to preeclamptic mothers were delivered by cesarean section (88% vs. 60%; P<0.0001) more often and had lower birthweight (median = 1265g, IQR 910-1555 vs. median = 1388g, IQR 959-1752; P=0.008) compared to infants born to non-preeclamptic mothers. Higher incidence of intrauterine growth restriction was noted in pre-eclampsia group, 24% vs. 8%, P=0.0001). Gestational age, length of stay and days on ventilator were all associated with the development of BPD. In multivariable logistic regression, pre-eclampsia was not a risk factor for development of BPD (OR 1.12 [0.68, 1.83]).
Conclusions: Pre-eclampsia was not a significant risk factor for development of BPD nor the severity of BPD in infants' ≤32 weeks' gestation. IUGR infants with or without pre-eclampsia mothers were at higher risk for BPD.
Similar articles
-
Preeclampsia and the Risk of Bronchopulmonary Dysplasia in Preterm Infants Less Than 32 Weeks' Gestation.Am J Perinatol. 2017 May;34(6):585-592. doi: 10.1055/s-0036-1594017. Epub 2016 Dec 5. Am J Perinatol. 2017. PMID: 27919118
-
Increased incidence of bronchopulmonary dysplasia in preterm infants exposed to preeclampsia.J Matern Fetal Neonatal Med. 2012 Dec;25(12):2681-5. doi: 10.3109/14767058.2012.708371. Epub 2012 Aug 8. J Matern Fetal Neonatal Med. 2012. PMID: 22759075
-
Risk factors of bronchopulmonary dysplasia depending on the severity of the disease in very preterm infants.J Matern Fetal Neonatal Med. 2025 Dec;38(1):2501697. doi: 10.1080/14767058.2025.2501697. Epub 2025 May 13. J Matern Fetal Neonatal Med. 2025. PMID: 40360451
-
Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.JAMA Netw Open. 2023 Mar 1;6(3):e233934. doi: 10.1001/jamanetworkopen.2023.3934. JAMA Netw Open. 2023. PMID: 36943265 Free PMC article.
-
Maternal preeclampsia and risk of bronchopulmonary dysplasia in preterm infants.Pediatr Res. 2012 Feb;71(2):210-4. doi: 10.1038/pr.2011.27. Epub 2011 Dec 21. Pediatr Res. 2012. PMID: 22258134 Review.
Cited by
-
The Relationship Between Severe Hypertensive Diseases of Pregnancy and Moderate-Severe Bronchopulmonary Dysplasia.Res Sq [Preprint]. 2023 Sep 29:rs.3.rs-3373933. doi: 10.21203/rs.3.rs-3373933/v1. Res Sq. 2023. Update in: J Perinatol. 2024 Jul;44(7):935-940. doi: 10.1038/s41372-024-01910-w. PMID: 37841860 Free PMC article. Updated. Preprint.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous